Investor Presentation November 2025.
TRANSPEK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transpek Industry reported Q2 FY26 revenue of ₹165.3 crore, down 1.5% YoY, but EBITDA grew 14.9% YoY to ₹31.7 crore with margin expanding to 19.2% from 16.5%, driven by a better product mix. H1 FY26 PAT surged nearly 50% YoY to ₹28.2 crore. For FY25, revenue was ₹678.6 crore (+12.2% YoY) with PAT of ₹48.7 crore (+26.4%). The company highlighted steady demand in domestic and export markets despite US tariff headwinds, a 10-year exclusive acid chloride supply deal with a global chemical giant, and recent entry into Eurasia and South America. Management has subscribed to a hybrid power project for cost savings expected from FY26-27 and won the EcoVadis Gold Medal for sustainability.
Margin expansion and strong H1 PAT growth signal operational improvement, but flat top line and US tariff risk on volumes/margins cap the upside. Shareholders should watch for new product commercialization and benefits from the hybrid power project in FY26-27, which could further support margins.